The University of Virginia Cancer Center seeks participants 18 years old or above to participate in a study that looks at a new treatment for follicular or marginal zone lymphoma that has not responded to or returned after previous treatments. The JCAR-017 treatment works on the T-cells in the body (part of the immune system).
Participation on this study involves up to 26 weeks. Participants are also required to take part in a 15-year long-term follow up study. Study-related tests and procedures and study drug will be covered by the study sponsor.
Additional information can be found here: https://clinicaltrials.gov/ct2/show/NCT04245839
You will not receive compensation for this trial. o Reimbursement: You will receive up to $.54 per mile to cover travel expenses. You will also receive up to $175 for lodging if you live over 50 miles away.